Ibuprofen 200 mg TEPI Medicated Plaster

DRUG2 trials

Sponsors

Medherant Ltd

Conditions

Healthy

Phase 1

Phase I Study to Assess Irritation, Sensitization and Adhesion of a Novel Ibuprofen 200 mg TEPI Medicated Plaster

CompletedNCT03639571

Medherant LtdHealthy

Start: 2018-08-09End: 2018-10-25Updated: 2019-04-17

pK of a Novel 200 mg Ibuprofen Medicated Plaster

CompletedNCT03694587

Medherant LtdHealthy

Start: 2018-09-25End: 2018-10-18Updated: 2019-04-16